tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

COLL Stock Latest News

Collegium Pharmaceutical price target raised to $58 from $55 at Truist
The FlyCollegium Pharmaceutical price target raised to $58 from $55 at Truist
8h ago
COLL
Collegium Pharmaceutical management to meet with Truist
PremiumThe Fly
Collegium Pharmaceutical management to meet with Truist
5d ago
COLL
Collegium price target lowered to $56 from $58 at Barclays
PremiumThe Fly
Collegium price target lowered to $56 from $58 at Barclays
1M ago
COLL
Collegium Pharmaceutical price target raised to $60 from $46 at H.C. Wainwright
PremiumThe Fly
Collegium Pharmaceutical price target raised to $60 from $46 at H.C. Wainwright
1M ago
COLL
Collegium Pharmaceutical: Strengthened 2026 Outlook, Balance Sheet Flexibility, and BD Upside Support Buy Rating and Higher Target
PremiumRatings
Collegium Pharmaceutical: Strengthened 2026 Outlook, Balance Sheet Flexibility, and BD Upside Support Buy Rating and Higher Target
1M ago
COLL
Collegium Issues 2026 Guidance Emphasizing Jornay PM Growth
PremiumCompany AnnouncementsCollegium Issues 2026 Guidance Emphasizing Jornay PM Growth
1M ago
8K
COLL
Collegium Pharmaceutical sees FY26 produce revenue $805M-$825M
Premium
The Fly
Collegium Pharmaceutical sees FY26 produce revenue $805M-$825M
1M ago
COLL
Collegium Pharmaceutical price target raised to $55 from $47 at Truist
Premium
The Fly
Collegium Pharmaceutical price target raised to $55 from $47 at Truist
1M ago
COLL
Collegium Pharmaceutical Closes New $980 Million Credit Facility
PremiumCompany Announcements
Collegium Pharmaceutical Closes New $980 Million Credit Facility
1M ago
8K
COLL
Collegium Pharmaceutical closes $980M syndicated credit facility
PremiumThe Fly
Collegium Pharmaceutical closes $980M syndicated credit facility
1M ago
COLL
Dyne Therapeutics appoints Vikram Karnani to board of directors
PremiumThe Fly
Dyne Therapeutics appoints Vikram Karnani to board of directors
2M ago
DYN
COLL
Collegium Pharmaceutical initiated with an Overweight at Barclays
PremiumThe Fly
Collegium Pharmaceutical initiated with an Overweight at Barclays
2M ago
COLL
Collegium Pharmaceutical price target raised to $48 from $45 at Truist
PremiumThe FlyCollegium Pharmaceutical price target raised to $48 from $45 at Truist
3M ago
COLL
Collegium Pharmaceuticals Reports Record Growth and Optimistic Outlook
Premium
Company Announcements
Collegium Pharmaceuticals Reports Record Growth and Optimistic Outlook
3M ago
COLL
Collegium Pharmaceutical price target raised to $46 from $44 at H.C. Wainwright
Premium
The Fly
Collegium Pharmaceutical price target raised to $46 from $44 at H.C. Wainwright
3M ago
COLL
Collegium Pharmaceutical Reports Record Q3 2025 Results
PremiumCompany Announcements
Collegium Pharmaceutical Reports Record Q3 2025 Results
3M ago
COLL
Collegium Pharmaceutical Reports Strong Q3 2025 Financial Results
PremiumCompany Announcements
Collegium Pharmaceutical Reports Strong Q3 2025 Financial Results
3M ago
8K
COLL
Collegium raises FY25 revenue view to $775M-$785M from $745M-$760M
PremiumThe Fly
Collegium raises FY25 revenue view to $775M-$785M from $745M-$760M
3M ago
COLL
Collegium Pharmaceutical reports Q3 adjusted EPS $2.25, consensus $1.86
PremiumThe Fly
Collegium Pharmaceutical reports Q3 adjusted EPS $2.25, consensus $1.86
3M ago
COLL
Collegium Pharmaceutical Inc. (COLL) Q3 Earnings Cheat Sheet
PremiumPre-EarningsCollegium Pharmaceutical Inc. (COLL) Q3 Earnings Cheat Sheet
3M ago
COLL
Collegium Pharmaceutical collaborates with Paris Hilton
Premium
The Fly
Collegium Pharmaceutical collaborates with Paris Hilton
3M ago
COLL
Collegium Pharmaceutical: Buy Rating Backed by Growth Potential and Strategic Product Integration
Premium
Ratings
Collegium Pharmaceutical: Buy Rating Backed by Growth Potential and Strategic Product Integration
4M ago
COLL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >